CN110272357A - A kind of preparation method of alkenyl cyanides - Google Patents

A kind of preparation method of alkenyl cyanides Download PDF

Info

Publication number
CN110272357A
CN110272357A CN201810210712.4A CN201810210712A CN110272357A CN 110272357 A CN110272357 A CN 110272357A CN 201810210712 A CN201810210712 A CN 201810210712A CN 110272357 A CN110272357 A CN 110272357A
Authority
CN
China
Prior art keywords
alkyl
aryl
independently
formula
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810210712.4A
Other languages
Chinese (zh)
Other versions
CN110272357B (en
Inventor
刘元红
张兴杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry of CAS
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN201810210712.4A priority Critical patent/CN110272357B/en
Publication of CN110272357A publication Critical patent/CN110272357A/en
Application granted granted Critical
Publication of CN110272357B publication Critical patent/CN110272357B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/08Preparation of carboxylic acid nitriles by addition of hydrogen cyanide or salts thereof to unsaturated compounds
    • C07C253/12Preparation of carboxylic acid nitriles by addition of hydrogen cyanide or salts thereof to unsaturated compounds to compounds containing carbon-to-carbon triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/06Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms of an acyclic and unsaturated carbon skeleton
    • C07C255/07Mononitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/06Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms of an acyclic and unsaturated carbon skeleton
    • C07C255/09Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms of an acyclic and unsaturated carbon skeleton containing at least two cyano groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/10Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and halogen atoms, or nitro or nitroso groups, bound to the same acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/15Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same unsaturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/35Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/36Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/0825Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083Syntheses without formation of a Si-C bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The preparation method of the invention discloses a kind of alkenyl cyanides as shown in Formula II comprising following steps: in organic solvent, under gas shield, at a temperature of 20 DEG C -100 DEG C, in Raney nickel, reducing agent and H2Under the action of O, alkynes and cyanylation agent shown in formula I are subjected to reduction reaction as follows, the alkenyl cyanides as shown in Formula II are made.Preparation method of the invention is easy to operate, reaction condition is mild using cheap nickel as catalyst system, and functional group compatibility is good, wide application range of substrates, reaction efficiency and high income, therefore application with higher and promotional value.

Description

A kind of preparation method of alkenyl cyanides
Technical field
The invention belongs to organic chemistry fileds, more particularly to a kind of preparation method of alkenyl cyanides.
Background technique
Cyano is the important functional group in organic synthesis, can carry out a variety of chemical conversioning reactions, can such as be converted into carboxylic Acid, aldehyde, ketone, ester, amide, amine, tetrazolium and other nitrogen heterocyclics etc..Further, since highly polar, the strong electrophilic of cyano Property and the features such as good metabolic stability one kind that cyano is become in pharmaceutical chemistry and materials chemistry research it is extremely important Functional group;Therefore the cyanalation reaction that the cyano functional groupization reaction of research organic molecule is especially catalyzed, which is undoubtedly to synthesize, to be had Project extremely important and with great challenge in chemical machine.
Hydrogen-cyanogenation of transition metal-catalyzed alkene or alkynes be synthesize alkenyl cyanogen or alkyl cyanide important method it One, as following documents is on the books:
(a)T.V.Rajanbabu,2011.Hydrocyanation of Alkenes and Alkynes.Organic Reactions.Volume 75,chapter 1,pp.1–74;
(b)A.L.Casalnuovo,T.V.Rajanbabu,Transition-metalcatalyzed alkene and alkyne hydrocyanations.In Transition Metals for Organic Synthesis:Building Blocks and Fine Chemicals;M.Beller,C.Bolm,Eds.;Wiley-VCH,2008;Chapter 2.5,and references therein;
(c)M.Beller,J.Seayad,A.Tillack,H.Jiao,Angew.Chem.,Int.Ed.2004,43, 3368-3398and references therein.
Above-mentioned reaction reported in the literature is to be descended and severe toxicity by alkene or alkynes in transition metal such as Ni, Pd or Co catalysis Hydrogen cyanide or the substrate such as cyanalation product of acetone cyanohydrin reaction generation that hydrogen cyanide can be generated, but hydrogen-cyaniding to alkynes Repercussion study is very limited.
The hydrogen of alkynes-cyanogenation research at present focuses primarily upon the alkynes of nickel catalysis grinding with hydrogen cyanide or acetone cyanohydrin Study carefully, but the regioselectivity of such reaction is poor, usually cannot get single hydrogen-cyaniding product.In addition, the substrate of reaction is general Adaptive and functional group compatibility are poor, and the efficiency and yield of reaction are to be improved.As recorded in having in following documents:
(d)W.R.Jackson,C.G.Lovel,J.Chem.Soc.Chem.Commun.1982,1231-1232;
In the reaction, obtained hydrocyanation product yield is lower, and 2 and 3 mixing yield is about 5~51%, and should Reaction cannot obtain single hydrocyanation product, and the ratio of products therefrom is about 2/3=9/1.
(e)W.R.Jackson,C.G.Lovel,Aust.J.Chem.1983,36,1975-1982;
(f)N.J.Fitzmaurice,W.R.Jackson,P.Perlmutter,J.Organomet.Chem.1985, 285,375-381.
Since hydrogen cyanide is severe toxicity and volatile liquid (bp27 DEG C), in the presence of base it is also possible to occurring explosive Polymerization reaction, the great risk in laboratory and industrial production, therefore it is special to develop safe and efficient hydrogen-cyanogenation It is that there is hydrogen-cyanogenation of high regio- and stereo-selectivity to seem especially urgent and needs.
Nearest Morandi etc. is reported on Science may be implemented no hydrogen cyanide ginseng using transfer hydrogen-cyaniding strategy With alkene hydrogen-cyanogenation.They pass through the C-CN key fracture of alkyl nitrile and β-H using nickel complex as catalyst Elimination reaction locally produces NC-Ni-H substance, and then insertion occurs and restores elimination reaction with alkene to obtain hydrogen-cyaniding product, Also have the hydrogen-cyanogenation of several alkynes in this article, but be confined to interior alkynes (X.Fang, P.Yu, B.Morandi, Science, 2016,351,832-836).Its reaction is as follows:
Therefore this field needs a kind of preparation method of safe and efficient, substrate wide adaptability alkenyl cyanides.
Summary of the invention
The technical problem to be solved by the present invention is to overcome in the preparation method of alkenyl cyanogen in the prior art, usually using acute Poison hydrogen cyanide as cyanogen source, and usually using valuableness catalyst, substrate narrow application range, severe reaction conditions, solid and Regioselectivity difference and the defects such as efficiency and yield are low, and then provide a kind of preparation method of alkenyl cyanides.This The preparation method of invention is easy to operate, reaction condition is mild using cheap nickel as catalyst system, and functional group compatibility is good, bottom Object is applied widely, reaction efficiency and high income, therefore application with higher and promotional value.
The present invention is to solve technical problem by the following technical programs.
The preparation method of the present invention provides a kind of alkenyl cyanides as shown in Formula II comprising following steps: In organic solvent, under gas shield, at a temperature of 20 DEG C -100 DEG C, in Raney nickel, reducing agent and H2It, will be as under the action of O Alkynes and cyanylation agent shown in Formulas I carry out reduction reaction as follows, and the alkenyl cyanogen class chemical combination as shown in Formula II is made Object;
Wherein, the cyanylation agent is selected from one of Cymag, potassium cyanide, nickel cyanide and zinc cyanide or a variety of;
The Raney nickel is selected from Ni (acac)2、Ni(cod)2、NiCl2·6H2O、NiCl2、NiBr2、NiBr2 (PPh3)2、NiCl2(dppf)、NiCl2(glyme)、NiBr2(DME)、NiF2And Ni (ClO4)26H2One of O or a variety of;
The reducing agent is manganese powder, zinc powder or iron powder;
R1And R2Independently be hydrogen, halogen, hydroxyl,C2-4Alkenyl, C1-10Alkane Base, by one or more R3Substituted C1-10Alkyl is (when there are multiple R3When, the R3It is identical or different), C3-8Naphthenic base, By one or more R4Substituted C3-8Naphthenic base is (when there are multiple R4When, the R4It is identical or different), C6-14Aryl, by one A or multiple R5Substituted C6-14Aryl is (when there are multiple R5When, the R5It is identical or different), C2-14Heteroaryl, by R6Replace C2-14Heteroaryl is (when there are multiple R6When, the R6It is identical or different), R1aAnd R1bIt independently is hydrogen, C1-4Alkyl or C6-14Aryl;R1cAnd R1dIt independently is C1-4Alkyl, C1-4Alkoxy or C6-14Virtue Base;
Each R3Independently be hydroxyl, halogen, cyano,C6-14Aryl, C2-4Alkenyl, C1-4Alkyl Or C2-14Heteroaryl;R3aAnd R3bIt independently is hydrogen, C6-14Aryl orR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;
Each R4It independently is hydroxyl, halogen, cyano or C1-4Alkyl;
Each R5Independently be hydroxyl, halogen, cyano,C6-14Aryl, C2-4Alkene Base, C2-4Alkynyl, C6-14The C that aryl replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkoxy, halogenated C1-4Alkyl, C3-6Naphthenic base orR5aAnd R5bIndependently be H orR5a1For C1-4Alkyl or benzyl;R5cFor amino or Sulfonic group;R5dFor C1-4Alkyl;
Each R6It independently is hydroxyl, halogen, cyano, C1-4Alkyl or C1-4Alkoxy;
R7、R8And R9It is each independently C6-14Aryl, C1-4Alkyl, C1-4Alkoxy or halogenated C1-4Alkyl;
The C2-14Hetero atom in heteroaryl is selected from O, N and S, and hetero atom number is 1-4, when hetero atom is multiple, The hetero atom is identical or different.
In the present invention, R1a、R1b、R1c、R1d、R3、R3a1、R4、R5、R5a1、R5d、R6、R7、R8Or R9In, the C1-4Alkyl It can be methyl, ethyl, n-propyl, isopropyl, normal-butyl, tert-butyl or isobutyl group, preferably methyl or ethyl.
In the present invention, R1Or R2In, the C1-10Alkyl can be methyl, ethyl, n-propyl, isopropyl, normal-butyl, uncle Butyl, isobutyl group, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl or positive decyl.
In the present invention, R1c、R1d、R5、R6、R7、R8Or R9In, the C1-4Alkoxy can be methoxyl group, ethyoxyl, the third oxygen Base, isopropoxy, n-butoxy, isobutoxy or tert-butoxy.
In the present invention, R5、R7、R8Or R9In the C that is preferably replaced by one or more halogens1-4Alkyl, wherein halogen is excellent Select F, Cl, Br or I;The C1-4Alkyl is as defined above described;Halogenated C of the present invention1-4Alkyl may be, for example ,-CF3
In the present invention, R1、R2、R3、R4、R5Or R6In, the halogen be preferably F, Cl, Br or I (for example, F, Cl or Br)。
In the present invention, R1、R2、R3Or R5Described in C2-4Alkenyl can be vinyl, 1- acrylic, 2- acrylic, 1- fourth Alkenyl, 2- n-butene base, 3- n-butene base,Preferred vinyl.
In the present invention, R1Or R2In, the C3-8Naphthenic base can be C3-6Naphthenic base, preferably cyclopropyl, cyclobutyl, ring penta Base or cyclohexyl.
In the present invention, R1、R2、R1a、R1b、R1c、R1d、R3、R3a、R3b、R5、R5a1、R5d、R7、R8Or R9In, the C6-14 Aryl can be phenyl, naphthalene, anthryl or phenanthryl, preferably phenyl.
In the present invention, R1、R2Or R3In, the C2-14Heteroaryl can for pyridyl group, thienyl, furyl, imidazole radicals, Pyranose, pyrimidine radicals, indyl, carbazyl, thiazolyl, quinolyl, isoquinolyl, indolizine base, benzothienyl, benzo furan It mutters base or benzothiazolyl, preferably pyridyl group.
In the present invention, describedIt can be trimethyl silicon substrate, triethyl group silicon substrate, fert-butyidimethylsilyl Silicon substrate, triisopropylsilyl or triphenyl silicon substrate, preferably triisopropylsilyl.
In the present invention, the compound of formula I can beWherein, R3Defined as described above, n is between 1-16 Integer.
In the present invention, the compound of formula I can beWherein R5It is defined as described above.
In a preferred embodiment of the invention, R1And R2It independently is hydrogen, C1-10Alkyl, by one or more R3It takes The C in generation1-10Alkyl (when there are multiple R3When, the R3It is identical or different), C3-8Naphthenic base, by one or more R4Replace C3-8Naphthenic base is (when there are multiple R4When, the R4It is identical or different), C6-20Aryl, by one or more R5Replace C6-20Aryl (when there are multiple R5When, the R5It is identical or different), C2-14Heteroaryl, Wherein, R1、R2、R3、R4、R5、R7、R8And R9It is defined as described above.
In a preferred embodiment of the invention, each R3It independently isHalogen,Cyano or C6-14 Aryl;R3aAnd R3bIt independently is hydrogen, C6-14Aryl orR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;Wherein R3、 R3a、R3b、R3cAnd R3a1It is defined as described above.
In a preferred embodiment of the invention, the R4For hydroxyl;Wherein R4It is defined as described above.
In a preferred embodiment of the invention, each R5It independently isC6-14Aryl, C2-4Alkenyl, C6-14Virtue The C that base replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkoxy, halogenated C1-4Alkyl orR5aAnd R5bSolely On the spot for H orR5a1For C1-4Alkyl or benzyl;R5cFor amino or sulfonic group;R5dFor C1-4Alkyl;Wherein R5、R5a、 R5b、R5c、R5a1And R5dIt is defined as described above.
In a preferred embodiment of the invention, R7、R8And R9It is each independently C1-4Alkyl.
In a preferred embodiment of the invention, each R5Selected from halogen, C2-4Alkenyl, C1-4Alkyl, C1-4Alkoxy or C6-14Aryl.
In a preferred embodiment of the invention, R1And R2It independently is C1-10Alkyl, by one or more R3Replace C1-10Alkyl, C6-20Aryl, by one or more R5Substituted C6-20Aryl, C2-14Heteroaryl or by R6Replace C2-14Heteroaryl;Wherein R1、R2、R3And R5It is defined as described above.
In a preferred embodiment of the invention, R1And R2One be H, another for halogen, hydroxyl,C2-4Alkenyl, C1-10Alkyl, by one or more R3Substituted C1-10Alkyl, C3-8Naphthenic base, by one or more R4Substituted C3-8Naphthenic base, C6-20Aryl, by one or more R5Substituted C6-20's Aryl, C2-14Heteroaryl, by R6Substituted C2-14Heteroaryl,Its Middle R1、R2、R1a、R1b、R1cAnd R1dIt is defined as described above.
In a preferred embodiment of the invention, R1And R2It is identical.
In a preferred embodiment of the invention, R1And R2It independently is hydrogen, C1-10Alkyl, by one or more R3It takes The C in generation1-10Alkyl (when there are multiple R3When, the R3It is identical or different), C3-8Naphthenic base, by one or more R4Replace C3-8Naphthenic base is (when there are multiple R4When, the R4It is identical or different), C6-20Aryl, by one or more R5Replace C6-20Aryl (when there are multiple R5When, the R5It is identical or different), C2-14Heteroaryl,
Each R3It independently isHalogen,Cyano or C6-14Aryl;R3aAnd R3bIndependently be hydrogen, C6-14Aryl orR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;
The R4For hydroxyl;
Each R5It independently isC6-14Aryl, C2-4Alkenyl, C6-14The C that aryl replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkoxy, halogenated C1-4Alkyl orR5aAnd R5bIndependently be H orR5a1For C1-4Alkyl or benzyl;R5cFor amino or sulfonic group;R5dFor C1-4Alkyl;
R7、R8And R9It is each independently C1-4Alkyl;
Wherein each substituent group is defined as described above.
In the present invention, the compound of formula I can be following any compound:
In preparation method of the invention, the cyanylation agent can be zinc cyanide.
In preparation method of the invention, the Raney nickel can be Ni (acac)2、NiCl2·6H2O、Ni(cod)2And Ni(ClO4)2 6H2One of O or a variety of, preferably Ni (acac).
In preparation method of the invention, the reducing agent can be manganese powder or zinc powder.
In preparation method of the invention, the organic solvent is selected from benzene,toluene,xylene, ether, Isosorbide-5-Nitrae-dioxy six Ring, tetrahydrofuran, methylene chloride, dichloroethanes, chloroform, acetonitrile, n,N-dimethylacetamide, methyl phosphamide and dimethyl are sub- One of sulfone is a variety of;Preferably acetonitrile and/or tetrahydrofuran;
The preparation method of the alkenyl cyanides of the present invention as shown in Formula II, can also be in the presence of ligand Reaction.
Ligand of the present invention can be this field such reaction conventional ligands, preferably bipyridyl (bipy), 4,4'-, bis- uncle Two pyridine of butyl -2,2'- (dtbbpy), 2,9- dimethyl -1,10- phenanthroline (neocuproine, neocuproine), triphenyl Phosphine (PPh3), 2,6- diisopropyl N-heterocyclic carbine (IPr), the double diphenylphosphine xanthenes of 9,9- dimethyl -4,5- (xantphos), triethyl phosphine, tributylphosphine (TBUP), tricyclohexyl phosphine (TCHP), double diphenylphosphine methane (dppm), diformazan Base Phenylphosphine (PMe2Ph), diphenyl methyl phosphine (PMePh2), bis- (diphenyl phosphine) ethane (dppe) of 1,2-, the bis- (diphenyl of 1,3- Phosphine) propane (dppp), bis- (diphenylphosphine) butane (dppb) of 1,4-, 4,5- bis- (di-t-butyl phosphine) -9,9- xanthphos (t) and one of 3- (dicyclohexyl phosphino-) -1- methyl -2- phenyl -1H- indoles (CM-phos) or more Bu-xantphos Kind, more preferable bipyridyl (bipy), 4,4'- di-t-butyl -2,2'-, bis- pyridine (dtbbpy), 2,9- dimethyl -1,10- phenanthrene are coughed up Quinoline (neocuproine, neocuproine), triphenylphosphine (PPh3), 2,6- diisopropyl N-heterocyclic carbine (IPr) and 9,9- bis- The bis- diphenylphosphine xanthenes (xantphos) of methyl -4,5-, one of or it is a variety of, for example, 2,9- dimethyl -1,10- phenanthrene is coughed up Quinoline (neocuproine, neocuproine) or the double diphenylphosphine xanthenes (xantphos) of 9,9- dimethyl -4,5-.
In preparation method of the invention, the molar ratio of the alkynes shown in formula I and the reducing agent can be 1:0.01 ~1:10, preferably 1:0.1~1:1 are more preferably 1:0.2~1:0.5.
In preparation method of the invention, the molar ratio of the alkynes shown in formula I and the Raney nickel can be 1: 0.01~1:1, preferably 1:0.02~1:0.5 are more preferably 1:0.02~1:0.05.
In preparation method of the invention, the molar ratio of the Raney nickel and the ligand can be 1:1~1:10, preferably It is more preferably 1:1.2 for 1:1~1:5.
In preparation method of the invention, when the Raney nickel includes the ligand, for example, NiCl2(dppf)、 Or NiBr2(PPh3)2When, the preparation reaction can not need that additional ligand is added.
In preparation method of the invention, the molar ratio of the alkynes and the cyanylation agent can be 1:0.1~1:10, compared with It is goodly 1:0.5~1:2, is more preferably 1:0.6~1:1.2, for example, 1:0.8.
In preparation method of the invention, the molal volume ratio of the alkynes shown in formula I and the solvent can be 0.01mmol/mL~1mmol/mL, preferably 0.15mmol/mL~0.5mmol/mL.
In preparation method of the invention, the molal volume ratio of the alkynes and water shown in formula I can be 0.5mmol/mL ~1.5mmol/mL, preferably 1mmol/mL.
In preparation method of the invention, preferably 25 DEG C to 80 DEG C of the reaction temperature.
In preparation method of the invention, when reducing agent is zinc powder, Raney nickel can be NiCl2·6H2O, ligand can For Xantphos, reaction temperature can be 80 DEG C.
In preparation method of the invention, the process answered can using in this field routine monitoring method (such as TLC, HPLC or NMR) it is monitored, as reaction end when generally being disappeared using alkynes or no longer being reacted.
It is the reaction time that the reaction time can be conventional for such reaction of this field, excellent in preparation method of the invention It selects 0.1 hour to 200 hours, further preferred 30 minutes to 24 hours.
In preparation method of the invention, the gas for protection can be the guarantor of the organic chemical reactions of this field routine Protect gas, preferably one of nitrogen, helium, argon gas and neon or a variety of, preferably nitrogen.
In preparation method of the invention, the reaction may also include following post-processing step: after reaction, filtering, Solvent is removed, pillar layer separation obtains target compound, and the pillar layer separation can be using the generic operation in this field Conventional method.The mixed solvent of eluant, eluent preferred alkane solvents and esters solvent, the alkane solvents and the ester The volume ratio of class solvent preferred 100:1~1:3, more preferable 50:1~3:1, for example, 30:1~10:1.Or eluant, eluent can be Alkane solvents, esters solvent and halogenated alkanes solvents, volume ratio can be 5:1:1~1:1:1, preferably 2:1:1.Described The preferred petroleum ether of alkane solvents, the esters solvent ethyl acetate, the preferred methylene chloride of the halogenated alkane.
In preparation method of the invention, the water can be water commonly used in the art, be not specially limited herein, only Meet reaction to require, may be, for example, deionized water.
The present invention also provides a kind of alkenyl cyanides as shown in Formula II,
Wherein, R1And R2It is as defined above described in text.
In the present invention, the Formula II compound can beWherein, R3It is defined as described above, n 1-16 Between integer.
In the present invention, the Formula II compound can beWherein R5It is defined as described above.
In the present invention, the Formula II compound can be following any compound:
In the present invention, the Formula II compound can be a certain individual isomer of the compound, i.e.,.
In the present invention, the structure of the Formula II compound can be determined by its mono-crystalline structures.
On the basis of common knowledge of the art, above-mentioned each optimum condition, can any combination to get each preferable reality of the present invention Example.
The reagents and materials used in the present invention are commercially available.
The positive effect of the present invention is that: preparation method provided by the invention uses Raney nickel cheap and easy to get And ligand, can safely, mildly, efficiently realize reacting for alkynes and the lesser cyanylation agent of toxicity, alkenyl is prepared Cyanides, avoiding the hydrogen cyanide in conventional method using severe toxicity is cyanylation agent.In addition, preparation method of the invention Use water as hydrogen source, has the advantages that green, economy.
Preparation method of the invention is safe, simple to operation, mild, efficient, also has good functional group compatibility and bottom Object universality etc. is specific, therefore application with higher and promotional value.
Detailed description of the invention
Fig. 1 is the mono-crystalline structures schematic diagram of the compounds of this invention 2q.
Specific embodiment
The present invention is further illustrated below by the mode of embodiment, but does not therefore limit the present invention to the reality It applies among a range.In the following examples, the experimental methods for specific conditions are not specified, according to conventional methods and conditions, or according to quotient The selection of product specification.
1 compound of embodiment (1a)
In the glove box full of nitrogen atmosphere, Ni (acac) is sequentially added into the reaction flask of 8.0mL2 (0.025mmol,6.4mg),Mn(0.1mmol,5.5mg),Zn(CN)2(0.4mmol, 47.0mg), to methyl phenylacetylene Then reaction flask is covered tightly outside lid removal glove box and is added with syringe by (0.5mmol, 58.1mg) and acetonitrile (2.5mL) Water (0.5mL) will be put into the oil bath for be previously heated to 25 DEG C after the lid sealing completely of reaction flask with insulating tape and be reacted, and 24 Stop reaction after hour, after reaction solution is cooled to room temperature, 10% ammonium hydroxide is added and is quenched, ethyl acetate extraction, washing, saturation chlorine Change sodium solution washing, anhydrous sodium sulfate is dried, filtered, is concentrated, direct silica gel column chromatography purifying, eluant, eluent: petroleum ether to petroleum Ether/ethyl acetate=100:1 gradient elution, product be yellow oily liquid 59.1mg, yield 83%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49, 126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
2 compound of embodiment (1a)
In the embodiment of the present invention 2-6, technical solution is substantially the same manner as Example 1, the difference is that only ligand difference.
Using 1 scheme of embodiment, bipyridyl is ligand, silica gel column chromatography purifying, eluant, eluent: petroleum ether to petroleum ether/second Acetoacetic ester=100:1 gradient elution, yield 82%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
3 compound of embodiment (1a)
Using 1 scheme of embodiment, 4,4'- di-t-butyl -2,2'-, bis- pyridine is ligand, silica gel column chromatography purifying, elution Agent: petroleum ether to petrol ether/ethyl acetate=100:1 gradient elution, yield 74%,1H NMR purity is greater than 98%.1H NMR (400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J =8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45, 129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
4 compound of embodiment (1a)
Using 1 scheme of embodiment, neocuproine is ligand, and silica gel column chromatography purifies, eluant, eluent: petroleum ether to petroleum ether/ Ethyl acetate=100:1 gradient elution, yield 88%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
5 compound of embodiment (1a)
Using 1 scheme of embodiment, triphenylphosphine is ligand, and silica gel column chromatography purifies, eluant, eluent: petroleum ether to petroleum ether/ Ethyl acetate=100:1 gradient elution, yield 72%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
6 compound of embodiment (1a)
Using 1 scheme of embodiment, 2,6- diisopropyl N-heterocyclic carbines are ligand, silica gel column chromatography purifying, eluant, eluent: stone Oily ether is to petrol ether/ethyl acetate=100:1 gradient elution, yield 84%,1H NMR purity is greater than 98%.1H NMR (400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J =8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45, 129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
7 compound of embodiment (1a)
In the embodiment of the present invention 7-8, technical solution is substantially the same manner as Example 1, the difference is that only catalyst not Together.
Using 1 scheme of embodiment, cyclo-octadiene base nickel is catalyst, silica gel column chromatography purifying, eluant, eluent: petroleum ether to stone Oily ether/ethyl acetate=100:1 gradient elution, yield 38%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57, 140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
8 compound of embodiment (1a)
Using 1 scheme of embodiment, perchlorate hexahydrate's nickel is catalyst, silica gel column chromatography purifying, eluant, eluent: petroleum ether to stone Oily ether/ethyl acetate=100:1 gradient elution, yield 67%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57, 140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
9 compound of embodiment (1a)
In the embodiment of the present invention 9, technical solution is substantially the same manner as Example 1, the difference is that only organic solvent difference.
Using 1 scheme of embodiment, tetrahydrofuran is solvent, and silica gel column chromatography purifies, eluant, eluent: petroleum ether to petroleum ether/ Ethyl acetate=100:1 gradient elution, yield 83%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
10 compound of embodiment (1b)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are nothing Color oily liquids 63.0mg, yield 79%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ3.83(s,3H), 5.96 (s, 1H), 6.19 (s, 1H), 6.92 (d, J=9.2Hz, 2H), 7.52 (d, J=8.4Hz, 2H)13C NMR(100MHz, CDCl3): δ 55.29,114.21,117.88,122.10,124.80,125.51,127.01,160.75.H RMS (EI) calculated value C10H9NO[M]+: 159.0684, measured value 159.0688.
11 compound of embodiment (1c)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, product are pale yellow Color oily liquids 61.4mg, yield 85%,1H NMR purity is greater than 98%.1H NMR(400MHz,C6D6):δ3.02(br,2H), 5.39 (s, 1H), 5,56 (s, 1H), 6.25 (dd, J=1.6,8.0Hz, 1H), 6.60 (t, J=2.0Hz, 1H), 6.76 (dd, J =0.8,8.0Hz, 1H), 6.89 (t, J=8.0Hz, 1H)13C NMR(100MHz,C6D6):δ112.10,115.18, 116.18,118.30,123.19,127.38,129.99,133.67,147.83.HRMS (ESI) calculated value C9H9N2[M+H]+: 145.0760 measured value 145.0759.
12 compound of embodiment (1d)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, product are white Solid 115.0mg, yield 83%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ5.19(s,2H),5.99 (s, 1H), 6.22 (s, 1H), 7.06 (br, 1H), 7.33-7.37 (m, 5H), 7.44 (d, J=8.0Hz, 2H), 7.51 (d, J= 8.8Hz,2H).13C NMR(100MHz,CDCl3):δ67.14,117.73,118.53,121.97,126.48,126.59, 127.15,128.22,128.38,128.56,135.65,139.34,153.06.HRMS (EI) calculated value C17H14N2O2[M]+: 278.1055 measured value 278.1054.
13 compound of embodiment (1e)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are nothing Color liquid 55.1mg, yield 77%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.44(s,3H),5.99 (s,1H),6.25(s,1H),7.22-7.32(m,4H).13C NMR(100MHz,CDCl3):δ19.99,117.84,123.13, 126.39,128.86,129.46,130.78,133.55,133.70,135.70.HRMS (EI) calculated value C10H9N[M]+: 143.0735 measured value 143.0731.
14 compound of embodiment (1f)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are shallow Yellow liquid 65.6mg, yield 73%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.14(s,1H), 6.39 (s, 1H), 7.43-7.45 (m, 2H), 7.50-7.58 (m, 2H), 7.85-7.88 (m, 2H), 8.10 (d, J=8.4Hz, 1H).13C NMR(100MHz,CDCl3):δ118.32,122.08,124.11,125.15,126.43,126.90,127.06, 128.62,130.07,130.11,131.66,133.54,134.65.HRMS (ESI) calculated value C13H10N[M+H]+: 180.0808 measured value 180.0807.
15 compound of embodiment (1g)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are shallow Yellow solid 58.3mg, yield 79%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.09(s,1H), 6.27(s,1H),7.09-7.13(m,2H),7.57-7.60(m,2H).13C NMR(100MHz,CDCl3): δ 116.04 (d, J= 22.0Hz), 117.47,121.77,127.63 (d, J=8.6Hz), 127.74 (d, J=1.9Hz), 128.47 (d, J= 3.3Hz), 163.48 (d, J=249.3Hz) .HRMS (EI) calculated value C9H6NF[M]+: 147.0484, measured value 147.0481.
16 compound of embodiment (1h)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are shallow Yellow liquid 62.9mg, yield 77%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.12(s,1H), 6.32 (s, 1H), 7.39 (d, J=8.4Hz, 2H), 7.53 (d, J=8.8Hz, 2H)13C NMR(100MHz,CDCl3):δ 117.22,121.76,126.91,128.38,129.14,130.69,135.89.HRMS (EI) calculated value C9H6NCl[M]+: 163.0189 measured value 163.0185.
17 compound of embodiment (1i)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are shallow Yellow liquid 74.4mg, yield 72%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.13(s,1H), 6.34 (s, 1H), 7.46 (d, J=8.8Hz, 2H), 7.55 (d, J=8.8Hz, 2H)13C NMR(100MHz,CDCl3):δ 117.16,121.88,124.17,127.15,128.47,131.15,132.12.HRMS (EI) calculated value C9H6NBr[M]+: 206.9684 measured value 206.9692.
18 compound of embodiment (1j)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are white Color solid 50.6mg, yield 51%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.25(s,1H),6.46 (s,1H),7.68-7.74(m,4H).13C NMR(100MHz,CDCl3): δ 117.01,121.87,123.60 (q, J= 270.9Hz), 126.03 (q, J=3.7Hz), 126.12,130.27,131.76 (q, J=32.8Hz), 135.60 (q, J= 1.5Hz) .HRMS (EI) calculated value C10H6NF3[M]+: 197.0452, measured value 197.0451.
19 compound of embodiment (1k)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=1:3, product are white Solid 46.3mg, yield 54%,1H NMR purity is greater than 98%.1H NMR(400MHz,DMSO-d6):δ6.47(s,1H),6.87 (s, 1H), 7.53 (br, 1H), 7.75 (d, J=8.4Hz, 2H), 7.98 (d, J=8.4Hz, 2H), 8.11 (br, 1H)13C NMR (100MHz,DMSO-d6):δ117.63,120.49,125.52,128.37,132.53,134.47,135.33, 167.06.HRMS (EI) calculated value C10H8N2O[M]+: 172.0637, measured value 172.0641.
20 compound of embodiment (1l)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are shallow Yellow solid 76.1mg, yield 74%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.07(s,1H), 6.32 (s, 1H), 7.36 (t, J=7.2Hz, 1H), 7.44 (t, J=7.6Hz, 2H), 7.56-7.65 (m, 6H)13C NMR (100MHz,CDCl3):δ117.63,122.34,126.04,126.91,127.47,127.64,127.84,128.83, 131.03,139.63,142.52.HRMS (EI) calculated value C15H11N[M]+: 205.0891, measured value 205.0889.
21 compound of embodiment (1m)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are shallow Yellow solid 58.3mg, yield 75%,1H NMR purity is greater than 98%.1H NMR(400MHz,C6D6): δ 5.08 (d, J= 10.4Hz, 1H), 5.34 (s, 1H), 5.48 (s, 1H), 5.56 (dd, J=0.8,17.4Hz, 1H), 6.41-6.48 (m, 1H), 7.04 (d, J=8.4Hz, 2H), 7.23 (d, J=8.4Hz, 2H)13C NMR(100MHz,C6D6):δ115.28,117.80, 122.58,126.13,126.95,127.09,132.06,136.14,139.18.HRMS (EI) calculated value C11H9N[M]+: 155.0735 measured value 155.0732.
22 compound of embodiment (1n)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are white Color solid 77.8mg, yield 68%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.09(s,1H),6.31 (s, 1H), 7.34 (t, J=7.2Hz, 3H), 7.52-7.55 (m, 6H)13C NMR(100MHz,CDCl3):δ88.44,91.49, 117.33,122.14,122.61,124.85,125.55,128.33,128.57,131.56,131.68,131.99.HRMS (EI) calculated value C17H11N[M]+: 229.0891, measured value 229.0888.
23 compound of embodiment (1o)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=3:1, product are white Solid 25.7mg, yield 39%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.17(s,1H),6.37 (s, 1H), 7.30-7.33 (m, 1H), 7.81-7.84 (m, 1H), 8.59 (dd, J=1.6,4.6Hz, 1H), 8.80 (d, J= 2.0Hz,1H).13C NMR(100MHz,CDCl3):δ116.69,120.15,123.57,128.28,129.97,133.12, 146.83,150.77.HRMS (EI) calculated value C8H6N2[M]+: 130.0531, measured value 130.0529.
24 compound of embodiment (1p)
Using 1 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are nothing Color liquid 14.5mg, yield 14%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ7.15-7.17(m, 2H),7.21-7.29(m,3H),7.36(s,6H).13C NMR(100MHz,CDCl3):δ114.27,120.13,128.50, 128.80,129.03,129.24,129.72,129.82,132.57,133.46,144.14.
25 compound of embodiment (2a)
In the glove box full of nitrogen atmosphere, Ni (acac) is sequentially added into the reaction flask of 8.0mL2 (0.025mmol,6.4mg),neocuproine(0.03mmol,6.2mg),Mn(0.25mmol,13.8mg),Zn(CN)2 Then reaction flask is covered tightly lid and moved by (0.4mmol, 47.0mg), 1- dodecyne (0.5mmol, 83.2mg) and acetonitrile (2.5mL) Glove box is outer out and water (0.5mL) is added with syringe, will be put into advance after the lid sealing completely of reaction flask with insulating tape It is heated to reacting in 50 DEG C of oil bath, stops reaction after 24 hours, after reaction solution is cooled to room temperature, water quenching is added and goes out, acetic acid second Ester extraction, washing, saturated sodium chloride solution washing, anhydrous sodium sulfate are dried, filtered, are concentrated, and direct silica gel column chromatography purifying is washed De- agent: petrol ether/ethyl acetate=100:1 gradient elution, product are colourless oil liquid 60.0mg, yield 62%,1H NMR Purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 0.88 (t, J=7.2Hz, 3H), 1.27-1.30 (m, 14H), 1.54- 1.57 (m, 2H), 2.25 (t, J=7.6Hz, 2H), 5.70 (s, 1H), 5.82 (s, 1H)13C NMR(100MHz,CDCl3):δ 14.04,22.61,27.48,28.54,29.15,29.23,29.41,29.48,31.82,34.57,118.70,123.35, 129.97.HRMS (EI) calculated value C13H22N[M-H]+: 192.1752, measured value 192.1757.
26 compound of embodiment (2b)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are Colourless liquid 42.0mg, yield 61%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ0.88-0.91(m, 3H), 1.24-1.36 (m, 6H), 1.52-1.59 (m, 2H), 2.25 (t, J=8.0Hz, 2H), 5.71 (s, 1H), 5.83 (s, 1H).13C NMR(100MHz,CDCl3):δ13.93,22.41,27.42,28.18,31.31,34.54,118.70,123.32, 130.01.HRMS (EI) calculated value C9H14N[M-H]+: 136.1126, measured value 136.1130.
27 compound of embodiment (2c)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are Colourless liquid 56.6mg, yield 79%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ3.54(s,2H), 5.68-5.69(m,1H),5.893-5.894(m,1H),7.20-7.22(m,2H),7.27-7.29(m,1H),7.32-7.36 (m,2H).13C NMR(100MHz,CDCl3):δ40.62,118.41,122.54,127.31,128.79,128.82,130.99, 135.47.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0730.
28 compound of embodiment (2d)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are Colourless liquid 61.7mg, yield 78%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.54 (t, J= 8.0Hz, 2H), 2.86 (t, J=8.0Hz, 2H), 5.61 (s, 1H), 5.79 (s, 1H), 7.16-7.22 (m, 3H), 7.27-7.31 (m,2H).13C NMR(100MHz,CDCl3):δ33.69,36.30,118.39,122.16,126.34,128.31,128.44, 130.89,139.46.HRMS (EI) calculated value C11H11N[M]+: 157.0891, measured value 157.0894.
29 compound of embodiment (2e)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=30:1, product are nothing Color liquid 56.1mg, yield 67%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.58-1.69(m, 4H), 2.29 (t, J=7.2Hz, 2H), 2.35 (t, J=7.2Hz, 2H), 3.68 (s, 3H), 5.74 (s, 1H), 5.86 (s, 1H) .13C NMR(100MHz,CDCl3):δ23.67,26.78,33.38,34.11,51.43,118.38,122.59,130.42, 173.49.HRMS (ESI) calculated value C9H17N2O2[M+NH4]+: 185.1285, measured value 185.1283.
30 compound of embodiment (2f)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, product are nothing Color liquid 50.3mg, yield 84%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.91-1.99(m, 2H),2.42-2.48(m,4H),5.86(s,1H),5.96(s,1H).13C NMR(100MHz,CDCl3):δ15.92,22.96, (32.96,117.68,118.46,120.63,132.11.HRMS EI) calculated value C7H8N2[M]+: 120.0687, measured value 120.0684.
31 compound of embodiment (2g)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, product are Colourless liquid 39.1mg, yield 60%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.01-2.08(m, 2H), 2.47 (t, J=7.2Hz, 2H), 3.58 (t, J=6.4Hz, 2H), 5.81 (s, 1H), 5.92 (s, 1H)13C NMR (100MHz,CDCl3): δ 29.87,31.56,43.13,118.16,121.40,131.58.HRMS (EI) calculated value C6H8NCl [M]+: 129.0345, measured value 129.0339.
32 compound of embodiment (2h)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=3:1, product are nothing Color liquid 59.2mg, yield 85%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.39-1.45(m, 2H), 1.55-1.64 (m, 4H), 2.26-2.29 (m, 3H), 3.63 (t, J=6.8Hz, 2H), 5.74 (s, 1H), 5.85 (s, 1H).13C NMR(100MHz,CDCl3):δ24.63,27.17,32.00,34.35,62.19,118.55,122.86, 130.35.HRMS (ESI) calculated value C8H14NO[M+H]+: 140.1070, measured value 140.1070.
33 compound of embodiment (2i)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, product are nothing Color liquid 54.1mg, yield 68%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ3.10(s,1H),5.22 (s,1H),5.98(s,1H),6.05(s,1H),7.34-7.40(m,5H).13C NMR(100MHz,CDCl3):δ73.95, 116.90,126.08,126.44,128.80,129.92,139.07.HRMS (EI) calculated value C10H9NO[M]+:159.0684, Measured value 159.0678.
34 compound of embodiment (2j)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, product are nothing Color liquid 76.9mg, yield 82%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.95-2.09(m, 2H),2.67-2.76(m,2H),2.78(s,1H),4.20(s,1H),5.95(s,1H),5.96(s,1H),7.18-7.20(m, 3H),7.26-7.30(m,2H).13C NMR(100MHz,CDCl3):δ31.13,36.91,71.25,116.95,126.08, 126.56,128.32,128.45,130.20,140.61.HRMS (EI) calculated value C12H13NO[M]+: 187.0997, measured value 187.0990.
35 compound of embodiment (2k)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=10:1, product are nothing Color liquid 62.0mg, yield 82%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.26(s,1H), 1.62-1.78(m,9H),2.10(s,1H),5.95(s,1H),6.10(s,1H).13C NMR(100MHz,CDCl3):δ21.24, (24.78,35.81,72.39,117.79,128.27,132.05.HRMS ESI) calculated value C9H17N2O[M+NH4]+: 169.1335 measured value 169.1333.
36 compound of embodiment (2l)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=10:1, product are shallow Yellow liquid 43.7mg, yield 71%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.53(s,3H), 2.46 (s, 1H), 5.25 (d, J=10.8Hz, 1H), 5.38 (d, J=17.2Hz, 1H), 5.94-6.01 (m, 2H), 6.08 (s, 1H).13C NMR(100MHz,CDCl3):δ26.79,73.52,115.24,117.28,128.82,129.51,140.32.HRMS (EI) calculated value C7H8NO[M-H]+: 122.0606, measured value 122.0600.
37 compound of embodiment (2m)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=30:1, product are shallow Yellow liquid 43.1mg, yield 54%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ3.93(s,2H), 4.11 (s, 1H), 5.97-5.98 (m, 2H), 6.57 (d, J=8.4Hz, 2H), 6.76 (t, J=7.2Hz, 1H), 7.18 (t, J= 7.2Hz,2H).13C NMR(100MHz,CDCl3):δ46.38,112.88,117.64,118.46,120.97,129.30, 130.70,146.25.HRMS (ESI) calculated value C10H11N2[M+H]+: 159.0917, measured value 159.0915.
38 compound of embodiment (2n)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=3:1, product are nothing Color liquid 63.0mg, yield 83%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.92(s,3H),4.50 (s, 2H), 5.86 (s, 1H), 5.99 (s, 1H), 7.26 (d, J=7.6Hz, 2H), 7.39-7.41 (m, 1H), 7.46 (t, J= 6.8Hz,2H).13C NMR(100MHz,CDCl3):δ22.35,51.15,117.35,119.18,127.82,128.39, 129.83,133.00,141.85,170.58.HRMS (ESI) calculated value C12H13N2O[M+H]+: 201.1022, measured value 201.1020.
39 compound of embodiment (2o)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are nothing Color liquid 73.2mg, yield 80%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ4.77(s,2H),5.37 (s, 1H), 5.88 (s, 1H), 6.55 (d, J=2.4Hz, 1H), 7.02 (d, J=2.4Hz, 1H), 7.11-7.15 (m, 1H), 7.18-7.21 (m, 2H), 7.63 (d, J=7.6Hz, 1H)13C NMR(100MHz,CDCl3):δ48.11,102.94, 109.05,116.71,119.18,120.12,121.22,122.21,127.72,128.71,131.19,135.65.HRMS (ESI) calculated value C12H11N2[M+H]+: 183.0917, measured value 183.0914.
40 compound of embodiment (2p)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, product are nothing Color liquid 2.6mg, yield 2%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 1.12 (d, J=7.6Hz, 18H), 1.25-1.32 (m, 3H), 6.21 (d, J=2.4Hz, 1H), 6.77 (d, J=2.8Hz, 1H)13C NMR(100MHz, CDCl3): δ 10.60,18.07,120.72,147.26.HRMS (EI) calculated value C12H23NSi[M]+: 209.1600, measured value 209.1593.
41 compound of embodiment (2q)
Using 25 scheme of embodiment, silica gel column chromatography is purified, eluant, eluent: petrol ether/ethyl acetate/methylene chloride=2:1: 1, product be white solid 135.6mg, yield 80%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ 0.88-0.93(m,1H),1.01-1.10(m,4H),1.20-1.27(m,4H),1.30-1.35(m,1H),1.42-1.50(m, 2H), 1.63-1.75 (m, 5H), 1.86 (d, J=12.0Hz, 1H), 2.00-2.05 (m, 2H), 2.12-2.18 (m, 1H), 2.27-2.45(m,4H),2.98(s,1H),5.72(s,1H),5.85(s,1H),6.09(s,1H).13C NMR(100MHz, CDCl3):δ14.10,17.18,20.47,23.63,31.33,32.51,32.53,33.68,35.38,36.03,36.47, 38.40,47.09,48.89,53.10,84.53,118.43,123.68,129.82,130.63,171.19,199.65.HRMS (ESI) calculated value C22H30NO2[M+H]+: 340.2271, measured value 340.2266.
The mono-crystalline structures of compound 2q are as shown in Figure 1.
42 compound of embodiment (2r)
Using 25 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=3:1, product are white Color solid 165.6mg, yield 74%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.29(s,9H), 2.46 (br, 8H), 3.48 (s, 2H), 4.24 (s, 1H), 5.96 (s, 1H), 6.18 (s, 1H), 7.15 (t, J=7.6Hz, 1H), 7.20-7.26 (m, 4H), 7.30 (d, J=8.0Hz, 2H), 7.36 (d, J=7.6Hz, 2H), 7.46 (s, 4H)13C NMR (100MHz,CDCl3):δ31.28,34.29,51.72,53.10,62.52,75.59,117.57,122.46,124.91, 125.78.127.05,127.31,127.78,128.35,128.46,128.85,130.78,134.76,141.88,144.98, 149.70.HRMS (EI) calculated value C31H35N3[M]+: 449.2831, measured value 449.2820.
43 compound of embodiment (3a)
In the glove box full of nitrogen atmosphere, NiCl is sequentially added into the reaction flask of 4.0mL2·6H2O (0.009mmol,2.1mg),Xantphos(0.012mmol,6.9mg),Zn(0.06mmol,3.9mg),Zn(CN)2 (0.24mmol, 28.2mg), hexichol list alkynes (0.3mmol, 53.5mg) and acetonitrile (1.5mL), then cover tightly lid for reaction flask It is outer and water (0.5mL) is added with syringe to remove glove box, with insulating tape will reaction flask lid sealing it is complete after be put into it is pre- It is first heated to reacting in 80 DEG C of oil bath, stops reaction after 10 hours, after reaction solution is cooled to room temperature, water quenching is added and goes out, acetic acid Ethyl ester extraction, washing, saturated sodium chloride solution washing, anhydrous sodium sulfate are dried, filtered, are concentrated, direct silica gel column chromatography purifying, Eluant, eluent: petrol ether/ethyl acetate=100:1 gradient elution, product are colourless oil liquid, yield 95%,1H NMR purity Greater than 98%.1H NMR(400MHz,CDCl3): δ 7.15 (d, J=7.6Hz, 2H), 7.21 (t, J=7.6Hz, 2H), 7.27 (t, J=7.2Hz, 1H), 7.35-7.36 (m, 6H)13C NMR(100MHz,CDCl3):δ114.22,120.07,128.46, 128.75,128.98,129.20,129.68,129.78,132.54,133.41,144.08.IR(neat):3051,3029, 2205,1606,1574,1490,1445,1399,1184,1079,1019,927,893,771,760,726,690cm-1.HRMS (ESI) calculated value C15H12N[M+H]+: 206.0964, measured value 206.0961.
44 compound of embodiment (3b)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, yield 93%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.30 (s, 3H), 2.36 (s, 3H), 7.02 (d, J= 8.0Hz, 2H), 7.07 (d, J=8.4Hz, 2H), 7.14 (d, J=8.4Hz, 2H), 7.23-7.28 (m, 3H)13C NMR (100MHz,CDCl3):δ21.26,21.33,113.10,120.45,128.58,129.14,129.62,129.66,129.81, (130.78,139.13,140.11,143.57.IR film): 3027,2921,2205,1606,1508,1448,1410,1379, 1322,1210,1184,1114,1040,1018,952,900,813,772,724,714cm-1.HRMS (ESI) calculated value C17H16N[M+H]+: 234.1277, measured value 234.1276.
45 compound of embodiment (3c)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=30:1, yield 96%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ3.77(s,3H),3.82(s,3H),6.72-6.76 (m,2H),6.86-6.89(m,2H),7.12-7.15(m,2H),7.19(s,1H),7.30-7.33(m,2H).13C NMR (100MHz,CDCl3):δ55.18,55.20,111.14,113.83,114.35,120.74,125.07,126.21,130.08, (131.41,142.70,159.92,160.57.IR film): 2965,2937,2831,2202,1601,1568,1508,1462, 1442,1424,1293,1247,1173,1111,1024,905,829,804,735cm-1.HRMS (ESI) calculated value C17H16NO2 [M+H]+: 266.1176, measured value 266.1172.
46 compound of embodiment (3d)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=50:1, yield 93%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.23 (s, 3H), 2.38 (s, 3H), 6.66 (d, J= 7.6Hz,1H),6.81-6.85(m,1H),7.10-7.27(m,6H),7.59(s,1H).13C NMR(100MHz,CDCl3):δ 19.45,19.88,113.86,119.67,125.62,126.46,128.67,129.11,129.51,129.59,130.41, (130.80,131.95,132.55,136.27,137.33,143.93.IR film): 3067,3023,2920,2210,1598, 1479,1458,1377,1288,1260,1230,1099,1020,905,765,754,729,720cm-1.HRMS (ESI) is calculated Value C17H19N2[M+NH4]+: 251.1543, measured value 251.1542.
47 compound of embodiment (3e)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, yield 92%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ6.91-6.97(m,2H),7.04-7.09(m,2H), 7.13-7.17(m,2H),7.31(s,1H),7.33-7.38(m,2H).13C NMR(100MHz,CDCl3): δ 112.95 (d, J= 1.5Hz), 115.83 (d, J=22.0Hz), 116.34 (d, J=22.0Hz), 119.72,128.31 (d, J=3.8Hz), 129.37 (d, J=3.8Hz), 130.76 (d, J=8.4Hz), 131.72 (d, J=8.3Hz), 143.00,161.83 (d, J= 22.8Hz), 164.33 (d, J=25.0Hz) .IR (film): 3076,2232,2208,1599,1505,1408,1374,1297, 1228,1158,1101,1037,1014,901,831,787,731,717,684cm-1.HRMS (ESI) calculated value C15H13F2N2[M +NH4]+: 259.1041, measured value 259.1042.
48 compound of embodiment (3f)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=100:1, yield 82%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ7.08-7.11(m,2H),7.21-7.24(m,2H), 7.29-7.35(m,5H).13C NMR(100MHz,CDCl3):δ113.69,119.38,128.95,129.43,130.12, (130.62,130.86,131.53,135.53,136.02,143.12.IR film): 3042,2209,1902,1779,1610, 1589,1489,1399,1366,1310,1222,1177,1092,1012,897,822,763,722,689cm-1.HRMS(EI) Calculated value C15H9NCl2[M]+: 273.0112, measured value 273.0119.
49 compound of embodiment (3g)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=10:1, yield 88%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ1.36-1.42(m,6H),4.34-4.42(m,4H), 7.22 (d, J=8.4Hz, 2H), 7.43-7.45 (m, 2H), 7.48 (s, 1H), 7.91-7.93 (m, 2H), 8.02-8.04 (m, 2H).13C NMR(100MHz,CDCl3):δ14.13,14.16,61.17,61.22,115.41,118.97,128.83, 129.46,129.65,130.17,131.34,131.43,136.34,137.15,144.03 165.47,165.50.IR is (thin Film): 2992,2948,2204,1734,1716,1699,1607,1563,1405,1364,1283,1 269,1182,1125, 1100,1017,925,856,777,770,740,701cm-1.HRMS (ESI) calculated value C21H23N2O4[M+NH4]+: 367.1652 measured value 367.1648.
50 compound of embodiment (3h)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=10:1, yield 87%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ7.37-7.46(m,2H),7.54(s,1H),7.55- 7.64(m,2H),7.68(s,1H),7.82-7.85(m,1H),7.89-7.94(m,2H),9.88(s,1H),9.98(s,1H) .13C NMR(100MHz,CDCl3):δ114.78,118.94,129.48,129.77,130.04,130.51,130.68, 131.04,133.04,133.84,134.44,134.82,136.62,137.08,143.68 190.96,190.98.IR is (thin Film): 2848,2748,2216,1737,1596,1474,1381,1227,1155,1141,912,89 5,801,783,713, 693,684cm-1.HRMS (EI) calculated value C17H11NO2[M]+: 261.0790, measured value 261.0789.
51 compound of embodiment (3i)
Using 43 scheme of embodiment, silica gel column chromatography purifying, eluant, eluent: petrol ether/ethyl acetate=5:1, yield 65% ,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ7.19-7.22(m,1H),7.35-7.43(m,2H),7.48 (s, 1H), 7.73 (dt, J=2.0,7.6Hz, 1H), 8.46 (d, J=2.0Hz, 1H), 8.55 (dd, J=1.6,4.8Hz, 1H), 8.60 (d, J=2.4Hz, 1H), 8.65 (dd, J=1.6,4.8Hz, 1H)13C NMR(100MHz,CDCl3):δ113.36, 118.56,123.42,123.91,128.30,128.96,136.01,136.15,142.30,149.37,150.52,150.61, 150.85.IR (film): 3034,2912,2213,1611,1583,1567,1479,1411,1184,1127,1023,8 95, 853,810,753cm-1.HRMS (ESI) calculated value C13H10N3[M+H]+: 208.0869, measured value 208.0868.
Comparative example 1
Using 1 scheme of embodiment, 1,10- ferrosin is ligand, silica gel column chromatography purifying, eluant, eluent: petroleum ether to petroleum Ether/ethyl acetate=100:1 gradient elution, yield 1%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57, 140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 2
Using 1 scheme of embodiment, 4,7- diphenyl -1,10- phenanthrolines are ligand, silica gel column chromatography purifying, eluant, eluent: stone Oily ether is to petrol ether/ethyl acetate=100:1 gradient elution, yield 7%,1H NMR purity is greater than 98%.1H NMR(400MHz, CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H).13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57, 140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 3
Using 1 scheme of embodiment, 2,9- dimethyl -4,7- biphenyl -1,10- phenanthrolenes are ligand, silica gel column chromatography Purifying, eluant, eluent: petroleum ether to petrol ether/ethyl acetate=100:1 gradient elution, yield 27%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49, 126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 4
Using 1 scheme of embodiment, 1,1'- bis- (diphenylphosphine) ferrocene are ligand, and silica gel column chromatography purifies, eluant, eluent: Petroleum ether is to petrol ether/ethyl acetate=100:1 gradient elution, yield 4%,1H NMR purity is greater than 98%.1H NMR (400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J =8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45, 129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 5
Using 1 scheme of embodiment, the bis- diphenylphosphine xanthenes of 9,9- dimethyl -4,5- are ligand, and silica gel column chromatography purifies, Eluant, eluent: petroleum ether to petrol ether/ethyl acetate=100:1 gradient elution, yield 20%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82, 129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 6
Using 1 scheme of embodiment, nickel iodide is catalyst, and silica gel column chromatography purifies, eluant, eluent: petroleum ether to petroleum ether/ Ethyl acetate=100:1 gradient elution, yield 18%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 7
Using 1 scheme of embodiment, diethylene glycol dimethyl ether nickelous bromide is catalyst, silica gel column chromatography purifying, eluant, eluent: stone Oily ether is to petrol ether/ethyl acetate=100:1 gradient elution, yield 7%,1H NMR purity is greater than 98%.1H NMR(400MHz, CDCl3): δ 2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H).13C NMR(100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57, 140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 8
Using 1 scheme of embodiment, reaction temperature is 0 DEG C, silica gel column chromatography purifying, eluant, eluent: petroleum ether to petroleum ether/second Acetoacetic ester=100:1 gradient elution, yield 3%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37(s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 9
Using 1 scheme of embodiment, reaction temperature is 150 DEG C, silica gel column chromatography purifying, eluant, eluent: petroleum ether to petroleum ether/ Ethyl acetate=100:1 gradient elution, yield 14%,1H NMR purity is greater than 98%.1H NMR(400MHz,CDCl3):δ2.37 (s, 3H), 6.02 (s, 1H), 6.27 (s, 1H), 7.21 (d, J=8.0Hz, 2H), 7.48 (d, J=8.0Hz, 2H)13C NMR (100MHz,CDCl3):δ21.14,117.79,122.63,125.49,126.82,129.45,129.57,140.04.HRMS (EI) calculated value C10H9N[M]+: 143.0735, measured value 143.0734.
Comparative example 10
Using 1 scheme of embodiment, cyanylation agent is changed to potassium ferrocyanide, bearing reaction cannot occur substantially.
Comparative example 11
Using 1 scheme of embodiment, cyanylation agent is changed to tetramethyl cyanogen silane, bearing reaction cannot occur substantially.
Comparative example 12
Using 1 scheme of embodiment, cyanylation agent is changed to acetonitrile, bearing reaction cannot occur substantially.
Comparative example 13
Using 1 scheme of embodiment, cyanylation agent is changed to cuprous cyanide, bearing reaction cannot occur substantially.

Claims (10)

1. a kind of preparation method of the alkenyl cyanides as shown in Formula II, which is characterized in that the preparation method include with Lower step: in organic solvent, under gas shield, at a temperature of 20 DEG C -100 DEG C, in Raney nickel, reducing agent and H2The effect of O Under, alkynes and cyanylation agent shown in formula I are subjected to reduction reaction as follows, the alkenyl cyanogen as shown in Formula II is made Class compound;
Wherein, the cyanylation agent is selected from one of Cymag, potassium cyanide, nickel cyanide and zinc cyanide or a variety of;
The Raney nickel is selected from Ni (acac)2、Ni(cod)2、NiCl2·6H2O、NiCl2、NiBr2、NiBr2(PPh3)2、 NiCl2(dppf)、NiCl2(glyme)、NiBr2(DME)、NiF2With Ni (ClO4)2 6H2One of O or a variety of;
The reducing agent is manganese powder, zinc powder or iron powder;
R1And R2Independently be hydrogen, halogen, hydroxyl,C2-4Alkenyl, C1-10Alkyl, quilt One or more R3Substituted C1-10Alkyl, C3-8Naphthenic base, by one or more R4Substituted C3-8Naphthenic base, C6-14Aryl, quilt One or more R5Substituted C6-14Aryl, C2-14Heteroaryl, by R6Substituted C2-14Heteroaryl,R1aAnd R1bIt independently is hydrogen, C1-4Alkyl or C6-14Aryl;R1cWith R1dIt independently is C1-4Alkyl, C1-4Alkoxy or C6-14Aryl;
Each R3Independently be hydroxyl, halogen, cyano,C6-14Aryl, C2-4Alkenyl, C1-4Alkyl or C2-14Heteroaryl;R3aAnd R3bIt independently is hydrogen, C6-14Aryl orR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;
Each R4It independently is hydroxyl, halogen, cyano or C1-4Alkyl;
Each R5Independently be hydroxyl, halogen, cyano,C6-14Aryl, C2-4Alkenyl, C2-4Alkynyl, C6-14The C that aryl replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkoxy, halogenated C1-4Alkyl, C3-6Naphthenic base orR5aAnd R5bIndependently be H orR5a1For C1-4Alkyl or benzyl;R5cFor amino or Sulfonic group;R5dFor C1-4Alkyl;
Each R6It independently is hydroxyl, halogen, cyano, C1-4Alkyl or C1-4Alkoxy;
R7、R8And R9It is each independently C6-14Aryl, C1-4Alkyl, C1-4Alkoxy or halogenated C1-4Alkyl;
The C2-14Heteroaryl in hetero atom be selected from O, N and S, hetero atom number be 1-4, when hetero atom be it is multiple when, it is described Hetero atom it is identical or different.
2. the preparation method of the alkenyl cyanides as described in claim 1 as shown in Formula II, which is characterized in that
When there are multiple R3When, the R3It is identical or different;
And/or when there are multiple R4When, the R4It is identical or different;
And/or when there are multiple R5When, the R5It is identical or different;
And/or when there are multiple R6When, the R6It is identical or different;
And/or R1a、R1b、R1c、R1d、R3、R3a1、R4、R5、R5a1、R5d、R6、R7、R8Or R9In, the C1-4Alkyl is methyl, second Base, n-propyl, isopropyl, normal-butyl, tert-butyl or isobutyl group, preferably methyl or ethyl;
And/or R1Or R2In, the C1-10Alkyl be methyl, ethyl, n-propyl, isopropyl, normal-butyl, tert-butyl, isobutyl group, N-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl or positive decyl;
And/or R1c、R1d、R5、R6、R7、R8Or R9In, the C1-4Alkoxy is methoxyl group, ethyoxyl, propoxyl group, isopropyl oxygen Base, n-butoxy, isobutoxy or tert-butoxy;
And/or R5、R7、R8Or R9In, the halogenated C1-4Alkyl is the C replaced by one or more halogens1-4Alkyl, wherein halogen Element is F, Cl, Br or I;The wherein C1-4Alkyl is methyl, ethyl, n-propyl, isopropyl, normal-butyl, tert-butyl or isobutyl Base, preferably methyl or ethyl;The halogenated C1-4Alkyl preferably-CF3
And/or R1、R2、R3、R4、R5Or R6In, the halogen is F, Cl, Br or I, preferably F, Cl or Br;
And/or R1、R2、R3Or R5In, the C2-4Alkenyl is vinyl, 1- acrylic, 2- acrylic, 1- cyclobutenyl, the positive fourth of 2- Alkenyl, 3- n-butene base,Preferred vinyl;
And/or R1Or R2In, the C3-8Naphthenic base is C3-6Naphthenic base, preferably cyclopropyl, cyclobutyl, cyclopenta or cyclohexyl;
And/or R1、R2、R1a、R1b、R1c、R1d、R3、R3a、R3b、R5、R5a1、R5d、R7、R8Or R9In, the C6-14Aryl be phenyl, Naphthalene, anthryl or phenanthryl;It is preferred that phenyl;
And/or R1、R2Or R3In, the C2-14Heteroaryl is pyridyl group, thienyl, furyl, imidazole radicals, pyranose, pyrimidine Base, indyl, carbazyl, thiazolyl, quinolyl, isoquinolyl, indolizine base, benzothienyl, benzofuranyl or benzo Thiazolyl, preferably pyridyl group;
And/or it is describedFor trimethyl silicon substrate, triethyl group silicon substrate, t-Butyldimethylsilyl, three isopropyls Base silicon substrate or triphenyl silicon substrate, preferably triisopropylsilyl;
And/or the compound of formula I isWherein, integer of the n between 1-16;
And/or the compound of formula I is
3. the preparation method of the alkenyl cyanides as described in claim 1 as shown in Formula II, which is characterized in that
R1And R2It independently is hydrogen, C1-10Alkyl, by one or more R3Substituted C1-10Alkyl, C3-8Naphthenic base, by one Or multiple R4Substituted C3-8Naphthenic base, C6-20Aryl, by one or more R5Substituted C6-20Aryl, C2-14Heteroaryl, Or
And/or each R3It independently isHalogen,Cyano or C6-14Aryl;R3aAnd R3bIndependently be hydrogen, C6-14Aryl orR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;
And/or the R4For hydroxyl;
And/or each R5It independently isC6-14Aryl, C2-4Alkenyl, C6-14The C that aryl replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkoxy, halogenated C1-4Alkyl orR5aAnd R5bIndependently be H orR5a1For C1-4Alkyl or benzyl;R5cFor amino or sulfonic group;R5dFor C1-4Alkyl;
And/or R7、R8And R9It is each independently C1-4Alkyl;
And/or each R5Selected from halogen, C2-4Alkenyl, C1-4Alkyl, C1-4Alkoxy or C6-14Aryl;
And/or R1And R2It is each independently C1-10Alkyl, by one or more R3Substituted C1-10Alkyl, C6-20Virtue Base, by one or more R5Substituted C6-20Aryl, C2-14Heteroaryl or by R6Substituted C2-14Heteroaryl;
And/or R1And R2In, one be H, another for halogen, hydroxyl, C2-4Alkene Base, C1-10Alkyl, by one or more R3Substituted C1-10Alkyl, C3-8Naphthenic base, by one or more R4Substituted C3-8 Naphthenic base, C6-20Aryl, by one or more R5Substituted C6-20Aryl, C2-14Heteroaryl, by R6Substituted C2-14's Heteroaryl,
And/or R1And R2It is identical.
4. the preparation method of the alkenyl cyanides as described in claim 1 as shown in Formula II, which is characterized in that
R1And R2It independently is hydrogen, C1-10Alkyl, by one or more R3Substituted C1-10Alkyl, C3-8Naphthenic base, by one Or multiple R4Substituted C3-8Naphthenic base, C6-20Aryl, by one or more R5Substituted C6-20Aryl, C2-14Heteroaryl,
Each R3It independently isHalogen,Cyano or C6-14Aryl;R3aAnd R3bIt independently is hydrogen, C6-14Aryl OrR3a1For C1-4Alkyl;R3cFor C1-4Alkoxy;
The R4For hydroxyl;
Each R5It independently isC6-14Aryl, C2-4Alkenyl, C6-14The C that aryl replaces2-4Alkynyl, C1-4Alkyl, C1-4Alkane Oxygroup, halogenated C1-4Alkyl orR5aAnd R5bIndependently be H orR5a1For C1-4Alkane Base or benzyl;R5cFor amino or sulfonic group;R5dFor C1-4Alkyl;
R7、R8And R9It is each independently C1-4Alkyl.
5. the preparation method of the alkenyl cyanides according to any one of claims 1-4 as shown in Formula II, feature exist In the compound shown in formula I is following any compound:
6. the preparation method of the alkenyl cyanides as described in claim 1 as shown in Formula II, which is characterized in that
The cyanylation agent is zinc cyanide;
And/or the Raney nickel is selected from Ni (acac)2、NiCl2·6H2O、Ni(cod)2And Ni (ClO4)26H2One in O Kind is a variety of;Preferably Ni (acac);
And/or the reducing agent is manganese powder or zinc powder;
And/or the organic solvent is selected from benzene,toluene,xylene, ether, Isosorbide-5-Nitrae-dioxane, tetrahydrofuran, dichloromethane One of alkane, dichloroethanes, chloroform, acetonitrile, n,N-dimethylacetamide, methyl phosphamide and dimethyl sulfoxide are a variety of; Preferably acetonitrile and/or tetrahydrofuran;
And/or the molar ratio of the alkynes shown in formula I and the reducing agent is 1:0.01~1:10, preferably 1:0.1 ~1:1 is more preferably 1:0.2~1:0.5;
And/or the molar ratio of the alkynes shown in formula I and the Raney nickel is 1:0.01~1:1, preferably 1: 0.02~1:0.5 is more preferably 1:0.02~1:0.05;
And/or the molar ratio of the Raney nickel and the ligand is 1:1~1:10, preferably 1:1~1:5, more preferably for 1:1.2;
And/or the molar ratio of the alkynes and the cyanylation agent is 1:0.1~1:10, preferably 1:0.5~1:2, more It goodly is 1:0.6~1:1.2, for example, 1:0.8;
And/or the molal volume ratio of the alkynes shown in formula I and the solvent is 0.01mmol/mL~1mmol/mL, compared with It goodly is 0.15mmol/mL~0.5mmol/mL;
And/or the molal volume ratio of the alkynes and water shown in formula I is 0.5mmol/mL~1.5mmol/mL, preferably For 1mmol/mL;
And/or the reaction temperature is 25 DEG C to 80 DEG C.
7. the preparation method of the alkenyl cyanides as described in claim 1 as shown in Formula II, which is characterized in that described anti- It should be carried out in the presence of ligand.
8. the preparation method of the alkenyl cyanides as claimed in claim 7 as shown in Formula II, which is characterized in that
The ligand is selected from bipyridyl, two pyridine of 4,4'- di-t-butyl -2,2'-, 2,9- dimethyl -1,10- phenanthroline, three The double diphenylphosphine xanthenes of Phenylphosphine, 2,6- diisopropyl N-heterocyclic carbine, 9,9- dimethyl -4,5-, triethyl phosphine, tributyl Bis- (diphenyl phosphine) ethane of phosphine, tricyclohexyl phosphine, double diphenylphosphine methane, dimethylphenylphosphine, diphenyl methyl phosphine, 1,2-, 1, Bis- (diphenylphosphine) propane of 3-, bis- (diphenylphosphine) butane of 1,4-, (the di-t-butyl phosphine) -9,9- of 4,5- bis- xanthphos, With one of 3- (dicyclohexyl phosphino-) -1- methyl -2- phenyl -1H- indoles or a variety of, preferably bipyridyl, the tertiary fourth of 4,4'- bis- Two pyridine of base -2,2'-, 2,9- dimethyl -1,10- phenanthroline, triphenylphosphine, 2,6- diisopropyl N-heterocyclic carbine and 9,9- One of bis- diphenylphosphine xanthenes of dimethyl -4,5- are a variety of, more preferable 2,9- dimethyl -1,10- phenanthroline or 9,9- The double diphenylphosphine xanthenes of dimethyl -4,5-.
9. a kind of alkenyl cyanides as shown in Formula II,
Wherein, R1And R2Definition it is as described in claim 1.
10. the alkenyl cyanides as claimed in claim 9 as shown in Formula II, which is characterized in that
The Formula II compound isWherein, R3Definition it is as described in claim 1, n is whole between 1-16 Number;
And/or the Formula II compound isWherein, R5Definition it is as described in claim 1;
And/or the Formula II compound is following any compound:
CN201810210712.4A 2018-03-14 2018-03-14 Preparation method of alkenyl cyanide compound Active CN110272357B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810210712.4A CN110272357B (en) 2018-03-14 2018-03-14 Preparation method of alkenyl cyanide compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810210712.4A CN110272357B (en) 2018-03-14 2018-03-14 Preparation method of alkenyl cyanide compound

Publications (2)

Publication Number Publication Date
CN110272357A true CN110272357A (en) 2019-09-24
CN110272357B CN110272357B (en) 2021-12-14

Family

ID=67957647

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810210712.4A Active CN110272357B (en) 2018-03-14 2018-03-14 Preparation method of alkenyl cyanide compound

Country Status (1)

Country Link
CN (1) CN110272357B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113754597A (en) * 2021-09-07 2021-12-07 凯美克(上海)医药科技有限公司 Benzhydrylpiperazine compound containing linear chain olefin and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ACS: "", 《STN REGISTRY》 *
W. ROY JACKSON,CRAIG G. LOVE1: "Nickel(0) Catalysed Additions of Hydrogen Cyanide to Alkynes:Stereochemistry, Mechanism, and Preparative Application", 《J. CHEM. SOC., CHEM. COMMUN.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113754597A (en) * 2021-09-07 2021-12-07 凯美克(上海)医药科技有限公司 Benzhydrylpiperazine compound containing linear chain olefin and preparation method thereof
CN113754597B (en) * 2021-09-07 2024-07-16 凯美克(上海)医药科技有限公司 Benzhydryl piperazine compound containing linear olefin and preparation method thereof

Also Published As

Publication number Publication date
CN110272357B (en) 2021-12-14

Similar Documents

Publication Publication Date Title
Fañanás‐Mastral et al. Enantioselective Synthesis of Tertiary and Quaternary Stereogenic Centers: Copper/Phosphoramidite‐Catalyzed Allylic Alkylation with Organolithium Reagents
Xu et al. Palladium-catalyzed Heck reaction of aryl chlorides under mild conditions promoted by organic ionic bases
Oi et al. Nitrogen-directed ortho-arylation and-heteroarylation of aromatic rings catalyzed by ruthenium complexes
Kostas et al. The first use of porphyrins as catalysts in cross-coupling reactions: a water-soluble palladium complex with a porphyrin ligand as an efficient catalyst precursor for the Suzuki–Miyaura reaction in aqueous media under aerobic conditions
Kwong et al. First enantioselective catalyst based on a chiral terpyridine: synthesis of new C2-symmetric 2, 2′: 6′, 2′′-terpyridine ligands and copper-catalyzed enantioselective cyclopropanation of alkenes
CN111484472B (en) Process for preparing alkylnitriles
Aydemir et al. Aminophosphine–palladium (II) complexes: Synthsesis, structure and applications in Suzuki and Heck cross-coupling reactions
Kilic et al. Fluorine/phenyl chelated boron complexes: synthesis, fluorescence properties and catalyst for transfer hydrogenation of aromatic ketones
Sawada et al. Preparation of new chiral bisoxazoline ligands for the catalytic asymmetric intramolecular cyclopropanation of α-diazo-β-keto phenyl sulfone to afford a useful bicyclo [3.1. 0] hexane derivative
Haberberger et al. Synthesis, Characterization and Catalytic Application of Iron Complexes Modified by Monodentate Phosphane Ligands
WO2013159229A1 (en) Silanyloxyaryl phosphine ligand and uses thereof in c-n cross-coupling
Holm et al. Thiol-functionalized 1, 2, 4-triazolium salt as carbene ligand precursor
CN110117237B (en) Preparation method of aromatic nitrile or alkenyl nitrile compound
CN105294667B (en) NNN ligand, its metal complex, preparation method and application
Dong et al. 4, 6-Dihydroxysalicylic Acid-Catalyzed Oxidative Condensation of Benzylic Amines and Aromatic Ketones for the Preparation of 2, 4, 6-Trisubstituted Pyridines and Its Application to Metal-Free Synthesis of G-Quadruplex Binding Ligands
Ay et al. Hydrothermal synthesis, structure, heterogeneous catalytic activity and photoluminescent properties of a novel homoleptic Sm (III)-organic framework
CN108380245A (en) A kind of novel bidentate phosphorus-azepine Cabbeen p-cymene type catalyzed by ruthenium complexes agent and preparation method thereof and synthesis application
CN108623495A (en) A kind of preparation method of aromatic nitriles or miscellaneous aromatic nitrile compounds
CN106000465B (en) A kind of method of aldehyde and the oxidative coupling reaction of two level amide
Kantam et al. Palladium complexes containing multidentate phenoxy–pyridyl–amidate ligands: Highly efficient catalyst for Heck coupling of deactivated aryl halides
Samiee et al. Cyclopalladated benzo [h] quinolinate complexes based on stabilized phosphonium-phosphine ylides: Synthesis, characterization, and application as catalyst in aqueous-phase Suzuki-Miyaura reaction
Fonseca et al. Synthesis of novel nitrogen-containing ligands for the enantioselective addition of diethylzinc to aldehydes
Mu et al. The highly efficient Suzuki–Miyaura cross-coupling reaction using cyclopalladated N-alkylferrocenylimine as a catalyst in aqueous medium at room temperature under ambient atmosphere
Krishna et al. Synthesis and catalytic activities of PdII–phosphine complexes modified poly (ether imine) dendrimers
Mešková et al. Highly sterically hindered binaphthalene-based monophosphane ligands: synthesis and application in stereoselective Suzuki–Miyaura reactions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant